GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year earlier, in 2023, and 1% at the start of 2021.

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

The new drug, sold under the name Victoza and made by Hikma Pharmaceuticals ... brand-name weekly injections sold for diabetes and weight loss as Ozempic and Wegovy by Novo Nordisk and Mounjaro ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...

Apart from Victoza, which was approved for Type 2 diabetes in 2010, liraglutide also underpins Novo’s older weight loss drug Saxenda and its insulin-degludec-based diabetes combination therapy ...